Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP IT: Infliximab Discontinuation in Crohn's Disease
NCT01817426Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2013
- Primary completion
- May 2020
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 4 trial of infliximab in Crohn's disease, sponsored by Rigshospitalet. Started Jan 2013; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01817426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817426.